Zobrazeno 1 - 10
of 76
pro vyhledávání: '"Peer Christiansen"'
Autor:
Stephen Hamilton-Dutoit, Maret L. Maliniak, Henrik Toft Sørensen, Kristina B. Christensen, Per Damkier, Peer Christiansen, Timothy L. Lash, Lindsay J Collin, Sinna Pilgaard Ulrichsen, Deirdre Cronin-Fenton, Rami Yacoub, Thomas P. Ahern
Publikováno v:
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast cancer research : BCR, vol. 23, no. 1, pp. 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research : BCR
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, no. 1, 103 . https://doi.org/10.1186/s13058-021-01480-1
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Breast Cancer Research : BCR
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, no. 1, 103 . https://doi.org/10.1186/s13058-021-01480-1
Collin, L J, Maliniak, M L, Cronin-Fenton, D P, Ahern, T P, Christensen, K B, Ulrichsen, S P, Damkier, P, Hamilton-Dutoit, S, Yacoub, R, Christiansen, P M, Sørensen, H T & Lash, T L 2021, ' Hypoxia-inducible factor-1α expression and breast cancer recurrence in a Danish population-based case control study ', Breast Cancer Research, vol. 23, 103 . https://doi.org/10.1186/s13058-021-01480-1
Breast Cancer Research, Vol 23, Iss 1, Pp 1-11 (2021)
Background Hypoxia-inducible factor-1α (HIF-1α) is a transcription factor that facilitates the adaptation of cancer cells to hypoxic conditions and may be prognostic of breast cancer recurrence. We evaluated the association of HIF-1α expression wi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c9e39bc949916f4137cca5c5dfff01a5
https://pure.au.dk/portal/da/publications/hypoxiainducible-factor1-expression-and-breast-cancer-recurrence-in-a-danish-populationbased-case-control-study(68e72280-51af-4af2-8ec1-638d84a3abdc).html
https://pure.au.dk/portal/da/publications/hypoxiainducible-factor1-expression-and-breast-cancer-recurrence-in-a-danish-populationbased-case-control-study(68e72280-51af-4af2-8ec1-638d84a3abdc).html
Autor:
Buket Öztürk Esen, Rikke Nørgaard Pedersen, Deirdre Cronin-Fenton, Lene Mellemkjær, Timothy L. Lash, Bent Ejlertsen, Peer Christiansen, Mette Nørgaard
Publikováno v:
J Natl Cancer Inst
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B Ö, Mellemkjær, L, Christiansen, P, Ejlertsen, B, Lash, T L, Nørgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years after Primary Diagnosis ', Journal of the National Cancer Institute, vol. 114, no. 3, pp. 391–399 . https://doi.org/10.1093/jnci/djab202
Pedersen, R N, Esen, B O, Mellemkjaer, L, Christiansen, P, Ejlertsen, B, Lash, T L, Norgaard, M & Cronin-Fenton, D 2022, ' The Incidence of Breast Cancer Recurrence 10-32 Years After Primary Diagnosis ', National Cancer Institute. Journal (Online), vol. 114, no. 3, pp. 391-399 . https://doi.org/10.1093/jnci/djab202
Background Extended, more effective breast cancer treatments have increased the prevalence of long-term survivors. We investigated the risk of late breast cancer recurrence (BCR), 10 years or more after primary diagnosis, and associations between pat
Autor:
Maj-Britt Jensen, Frederik Cold, Peer Christiansen, Søren Cold, Deirdre Cronin-Fenton, Bent Ejlertsen
Publikováno v:
SSRN Electronic Journal.
Background: Women treated for breast cancer (BC) often suffer genitourinary syndrome of menopause. These symptoms may be alleviated by vaginal or systemic hormonal treatment. However, there are concerns that hormonal treatment increases the risk of r
Autor:
Anders Kjærsgaard, Peer Christiansen, Lauren E. McCullough, Thomas P. Ahern, Deirdre Cronin-Fenton, Timothy L. Lash, Lance A. Waller, Maj-Britt Jensen, Lindsay J Collin, Michael Goodman, Henrik Toft Sørensen, Per Damkier, Bent Ejlertsen
PurposePremenopausal women diagnosed with estrogen receptor (ER) positive breast cancer are prescribed 5–10 years of endocrine therapy to prevent or delay recurrence. Many women who initiate endocrine therapy fail to complete the recommended course
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::643a134db3e30868059dad6b389b5242
https://doi.org/10.1101/2020.10.13.20212217
https://doi.org/10.1101/2020.10.13.20212217
Autor:
Søren Feddersen, Cathrine Bredal Lythjohan, Thomas P. Ahern, Deirdre Cronin-Fenton, Anders Kjærsgaard, Peer Christiansen, Timothy L. Lash, Bent Ejlertsen, Per Damkier, Stephen Hamilton-Dutoit
Publikováno v:
Ahern, T P, Damkier, P, Feddersen, S, Kjærsgaard, A, Lash, T L, Hamilton-Dutoit, S, Lythjohan, C B, Ejlertsen, B, Christiansen, P M & Cronin-Fenton, D P 2020, ' Predictive pharmacogenetic biomarkers for breast cancer recurrence prevention by simvastatin ', Acta Oncologica, vol. 59, no. 9, pp. 1009-1015 . https://doi.org/10.1080/0284186X.2020.1759820
Acta Oncol
Acta Oncol
Background: Statins treat hyperlipidemia and prevent cardiovascular morbidity and mortality. Evidence suggests that they also have anti-neoplastic activity. Several studies show a reduced rate of breast cancer recurrence among lipophilic statin users
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7599fe9f231f4b44d03ae47875a0159e
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
https://pure.au.dk/portal/da/publications/predictive-pharmacogenetic-biomarkers-for-breast-cancer-recurrence-prevention-by-simvastatin(7c8b40dd-4ca1-411d-acd7-29ae79244b9e).html
Autor:
M.T.F.D. Vrancken Peeters, R.A.E.M. Tollenaar, E. Heeg, M.B. Jensen, Peer Christiansen, Bent Ejlertsen, Marc A.M. Mureau
Publikováno v:
Breast Cancer Research and Treatment, 182(3), 709-718. SPRINGER
Breast Cancer Research and Treatment
Heeg, E, Jensen, M B, Mureau, M A M, Ejlertsen, B, Tollenaar, R A E M, Christiansen, P M & Vrancken Peeters, M T F D 2020, ' Breast-contour preserving procedures for early-stage breast cancer : a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands ', Breast Cancer Research and Treatment, vol. 182, no. 3, pp. 709-718 . https://doi.org/10.1007/s10549-020-05725-z
Breast Cancer Research and Treatment
Heeg, E, Jensen, M B, Mureau, M A M, Ejlertsen, B, Tollenaar, R A E M, Christiansen, P M & Vrancken Peeters, M T F D 2020, ' Breast-contour preserving procedures for early-stage breast cancer : a population-based study of the trends, variation in practice and predictive characteristics in Denmark and the Netherlands ', Breast Cancer Research and Treatment, vol. 182, no. 3, pp. 709-718 . https://doi.org/10.1007/s10549-020-05725-z
Purpose Breast-contour preservation (BCP) is possible for most women treated for early-stage breast cancer. BCP can be defined as primary breast-conserving treatment (BCT), neoadjuvant chemotherapy (NAC) followed by BCT and immediate postmastectomy b
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::38648ffb3e234e8a674854b52cd34809
https://link.springer.com/article/10.1007/s10549-020-05725-z
https://link.springer.com/article/10.1007/s10549-020-05725-z
Autor:
Trine Tramm, Stephen Hamilton-Dutoit, James W. Baurley, Kristina Lystlund Lauridsen, Per Damkier, Anders Kjærsgaard, Peer Christiansen, Lindsay J Collin, Kristina B. Christensen, Maret L. Maliniak, Rebecca A. Silliman, Deirdre Cronin-Fenton, Timothy L. Lash, Michael E. Zwick, Thomas P. Ahern, Bent Ejlertsen, R. Benjamin Isett, Rebecca Nash, Henrik Toft Sørensen
Publikováno v:
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K, Silliman, R A, Toft Sørensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin-Fenton, D 2020, ' Metabolic Pathway Analysis and Effectiveness of Tamoxifen in Danish Breast Cancer Patients ', Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Ahern, T P, Collin, L J, Baurley, J W, Kjærsgaard, A, Nash, R, Maliniak, M L, Damkier, P, Zwick, M E, Isett, R B, Christiansen, P M, Ejlertsen, B, Lauridsen, K L, Christensen, K B, Silliman, R A, Toft Sorensen, H, Tramm, T, Hamilton-Dutoit, S, Lash, T L & Cronin Fenton, D 2020, ' Metabolic pathway analysis and effectiveness of tamoxifen in Danish breast cancer patients ', Cancer Epidemiology, Biomarkers & Prevention, vol. 29, no. 3, pp. 582-590 . https://doi.org/10.1158/1055-9965.EPI-19-0833
Cancer Epidemiol Biomarkers Prev
Background: Tamoxifen and its metabolites compete with estrogen to occupy the estrogen receptor. The conventional dose of adjuvant tamoxifen overwhelms estrogen in this competition, reducing breast cancer recurrence risk by nearly half. Phase I metab
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1801d69fb5cd7b94c2ec62c58bf25321
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
https://findresearcher.sdu.dk:8443/ws/files/162520147/1055_9965.EPI_19_0833.full.pdf
Autor:
Sinna Pilgaard Ulrichsen, Henrik Toft Sørensen, Lauren E. McCullough, Michael Goodman, Kristina B. Christensen, Kristina Lystlund Lauridsen, Per Damkier, Rami Yacoub, Lance A. Waller, Timothy L. Lash, Thomas P. Ahern, Bent Ejlertsen, Deirdre Cronin-Fenton, Peer Christiansen, Lindsay J Collin, Stephen Hamilton-Dutoit
Publikováno v:
Collin, L J, Ulrichsen, S P, Ahern, T P, Goodman, M, McCullough, L E, Waller, L A, Bang Christensen, K, Damkier, P, Hamilton-Dutoit, S, Lauridsen, K L, Yacoub, R, Christiansen, P M, Ejlertsen, B, Sørensen, H T, Cronin-Fenton, D P & Lash, T L 2020, ' 17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence : a Danish population-based study ', Acta Oncologica, vol. 59, no. 3, pp. 329-333 . https://doi.org/10.1080/0284186X.2019.1684560
Acta Oncol
Acta Oncol
BACKGROUND: Approximately 20–40% of patients diagnosed with breast cancer will experience a recurrence up to 20 years after their original diagnosis. 17?-hydroxysteroid dehydrogenase 1 and 2 (HSD17B1 and HSD17B2, respectively) regulate intratumoral
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b1221ea8ab1bf3d1024c9bb6d4f0751
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
https://portal.findresearcher.sdu.dk/da/publications/2ac08303-0b6f-4061-acbe-e409048b9d9c
Autor:
Vibeke Jensen, Peer Christiansen, Giedrius Lelkaitis, Sarah Schulz Nielsen, Marianne Djernes Lautrup, Anne Marie Bak Jylling
Publikováno v:
Breast Cancer (Tokyo, Japan)
Jylling, A M B, Jensen, V, Lelkaitis, G, Christiansen, P, Nielsen, S S & Lautrup, M D 2020, ' Male breast cancer : clinicopathological characterization of a National Danish cohort 1980–2009 ', Breast Cancer, vol. 27, no. 4, pp. 683-695 . https://doi.org/10.1007/s12282-020-01066-3
Jylling, A M B, Jensen, V, Lelkaitis, G, Christiansen, P, Nielsen, S S & Lautrup, M D 2020, ' Male breast cancer : clinicopathological characterization of a National Danish cohort 1980–2009 ', Breast Cancer, vol. 27, no. 4, pp. 683-695 . https://doi.org/10.1007/s12282-020-01066-3
Background To describe relevant pathological parameters of Danish male breast cancer patients (MBCP) diagnosed from 1980 to 2009, and to relate these data to treatment, overall survival (OS) and standardized mortality rate (SMR). Materials and method
Autor:
Trine Tramm, Peer Christiansen, Jens Overgaard, Vibeke Jensen, Tinne Laurberg, Christina D Lyngholm, Jan Alsner
Publikováno v:
Laurberg, T, Alsner, J, Tramm, T, Jensen, V, Lyngholm, C D, Christiansen, P M & Overgaard, J 2017, ' Impact of age, intrinsic subtype and local treatment on long-term local-regional recurrence and breast cancer mortality among low-risk breast cancer patients ', Acta Oncologica, vol. 56, no. 1, pp. 59-67 . https://doi.org/10.1080/0284186X.2016.1246803
Aim: To evaluate the long-term prognostic impact of age, local treatment and intrinsic subtypes on the risk of local-regional recurrence (LRR) and breast cancer mortality among low-risk patients. Material and methods: Cohort study with prospectively